Botanical & Bioactive Pharmaceutical API Manufacturer
Verified via 1H-NMR and HPLC-DAD with complete COA, DMF/CEP, and stability dossier support for generic drug manufacturing and R&D formulation partners.
✓ CSO VERIFIEDMitigating Isomeric Impurities, Solvents Exceedance & Regulatory Filing Delays
Scaling up active pharmaceutical ingredients (APIs) from pilot stage to commercial batch manufacturing carries critical quality risks. Unidentified degradation isomers, trace organic solvent carryover, or non-compliant stability dossiers can trigger regulatory holds and costly formulation reformulations.
Isomeric Impurities & Batch-to-Batch Inconsistency
Unidentified regio-isomers or unverified crystal polymorphism directly cause loss of bio-activity, unpredictable pharmacokinetic dissolution profiles, and variable drug release. Standard HPLC assay testing often fails to isolate inactive optical isomers during routine batch release.
- 1H-NMR & Chiral HPLC: Absolute structural identity & ≥99.0% trans-isomer purity.
- Jet-Milling Particle Size Control: Tight D90 < 10µm laser diffraction monitoring for batch dissolution uniformity.
Residual Solvent (USP <467>) & Heavy Metal Carryover
Class 2/3 solvent limits or trace element contamination (Lead, Arsenic, Cadmium, Mercury) exceeding strict ICH thresholds risk instant regulatory customs holds, audit non-compliance, or mandatory inventory destruction in North American and European markets.
- HS-GC-MS Solvent Screening: Strictly compliant with USP <467> / ICH Q3C Class 2 limits (e.g., n-Hexane ≤ 290 ppm).
- ICP-MS Elemental Profiling: Heavy metals validated < 1 ppm with ultra-trace detection capabilities.
Incomplete Technical Dossiers Delaying Drug Registration
Procuring APIs without complete Drug Master Files (DMF), Certificates of Suitability (CEP), or standardized stability data paralyzes pharmaceutical registration, forcing formulation partners to spend months generating retrospective validation data.
- eCTD Format DMF / CEP Dossiers: Full regulatory package including synthesis route & impurity profiles.
- ICH Q1A(R2) Stability Data: Accelerated (40°C/75% RH) and real-time stability testing documentation.
Leading 29-year veteran supplier of bulk Pharmaceutical APIs. USP/EP/BP compliant Paracetamol, Berberine HCl & Intermediates. GMP factory with DMF/CEP support.
Analgesics & Antipyretics
Global leading supply of Paracetamol (Acetaminophen) API. Engineered for large-scale manufacturing with optimized flowability.
Metabolic & Cardiovascular APIs
Specializing in Berberine HCl (97%+) and metabolic modulators with strict impurity profile control and fingerprint ID.
Advanced Chemical Intermediates
High-purity monomers and building blocks for Drug Discovery and complex chemical synthesis projects.
Integrated Purification, Synthesis, Isomeric Resolution & Particle Engineering
Bridging laboratory discovery and industrial commercial manufacturing. Our core proprietary technology platforms guarantee strict batch reproducibility, crystal polymorphism control, trace impurity clearance, and custom physical particle modification for global bio-pharmaceutical partners.
Controlled Botanical Extraction & Purification
Industrial-scale industrial chromatography and multi-stage continuous crystallizers engineered for standardized phytochemical APIs and bio-active secondary metabolites.
- Target Purity Scaling: Continuous preparative column isolation driving purity from raw biomass to ≥99.0%.
- Polyphenol & Glycoside Fractionation: Molecular-weight cut-off membrane filtration to purge heavy tannins and dark pigments.
- Trace Pesticide Stripping: Supercritical $CO_2$ and adsorption resin purging compliant with EP 2.8.13 limits.
Synthetic & Semi-Synthetic API Engineering
Multi-step organic synthesis and scalable bio-catalytic engineering platforms tailored for high-potency intermediates and rare bioactive molecules.
- Multi-Kilogram to Metric Ton Reaction Lines: Glass-lined and stainless steel reactors operating from -80°C to +200°C.
- Heavy Metal Scavenging: Palladium & Nickel catalyst removal achieving residual metals < 1 ppm (ICP-MS verified).
- Genotoxic Impurity Control: Targeted synthesis route optimization complying with ICH M7 guidelines.
Chiral & Isomeric Resolution ($^1\text{H-NMR}$ / HPLC-DAD)
Enantiomeric purity assurance and high-resolution analytical verification platforms securing absolute spatial structure identity for target active molecules.
- Enantiomeric Excess Validation: Chiral HPLC separation guaranteeing ≥99.5% optical purity ($ee\%$).
- $^1\text{H-NMR}$ & $13\text{C-NMR}$ Structural Proof: Unambiguous proton/carbon resonance assignment matching USP reference spectra.
- LC-MS/MS Impurity Profiling: Full identification and quantitation of unknown trace degradation markers down to 0.05%.
Custom Particle Engineering (Jet-Milling $D_{90} < 10\,\mu\text{m}$)
Fluid-energy jet-milling, spray drying, and crystal habit modification to optimize powder flowability, bulk density, and gastrointestinal dissolution speed.
- Ultra-Fine Micronization: Nitrogen-cooled jet-milling achieving precise $D_{90} < 10\,\mu\text{m}$ or $D_{50} < 2\,\mu\text{m}$.
- Laser Diffraction PSD Monitoring: Malvern Mastersizer 3000 particle size distribution curve attached to every COA.
- Bulk Density & Tap Density Control: Tailored particle morphology preventing agglomeration in high-speed capsule filling.
Active Pharmaceutical Ingredients (APIs) & Intermediates Specification Database
Direct manufacturer supply of cGMP, USP/EP/BP compliant active pharmaceutical ingredients. Filter batch availability, access full regulatory technical dossiers (DMF, COA, $^1\text{H-NMR}$), and secure regional DDP dispatch.
| API / Active Ingredient | CAS Number | Pharmacopeia Grade | Key Assay / Purity | Regulatory Dossier | Stock & Delivery | Action |
|---|---|---|---|---|---|---|
| Paracetamol API Acetaminophen | 103-90-2 | USP / EP / BP | ≥ 99.5% |
US DMF
COA
Stability Data | ● In Stock (2,700kg) | Inquire RFQ |
| Berberine HCl API Natural Botanical API | 633-65-8 | Pharma Grade | ≥ 98.0% (HPLC) |
COA
TDS
Impurity Profile | ● In Stock (1,000kg) | Inquire RFQ |
| Berberine Sulfate High Bioavailability Salt | 316-41-6 | Pharma Grade | ≥ 98.0% (HPLC) |
COA
Specification
MSDS | ● Ready to Ship | Inquire RFQ |
| Adenine Nucleobase Intermediate | 73-24-5 | Pharma Grade | ≥ 99.0% |
COA
Analytical Package | ● Custom Bulk Order | Inquire RFQ |
| Resveratrol (Pharma API) Trans-Isomer Micronized | 501-36-0 | USP Grade | ≥ 99.0% Trans-Isomer |
COA
1H-NMR
Stability Data | ● US Warehouse Stock | Inquire RFQ |
High-Purity Bioactive Ingredients & Pharmacopeial Standard Raw Materials
Reliability in pharmaceutical and high-end nutraceutical supply chains is built on structural purity, low solvent residuals, and complete regulatory transparency. Fast local DDP dispatch from US/EU hubs with batch-specific COA, 1H-NMR, and stability dossiers.
Batch-Level Analytical Verification & Technical Dossier Center
Eliminating batch uncertainty for global bio-pharmaceutical and high-potency raw material procurement. Every production batch undergoes rigorous spectral authentication, impurity profiling, and residual solvent clearance before release.
1H-NMR & 13C-NMR Resonance Proof
500 MHz high-field Bruker NMR spectroscopy confirming unambiguous proton and carbon resonance chemical shifts matching reference standard spectra.
- Absolute Isomeric Purity
- Conformational Fingerprint
- Zero Structural Ambiguity
HPLC-DAD Chromatographic Fingerprint
Ultra-high-performance liquid chromatography paired with diode-array detection (HPLC-DAD) quantifying key assay percentage and related substances down to 0.01%.
- Peak Purity Spectral Overlay
- Quantitated Trace Impurities
- ICH Q2(R1) Validated Method
HS-GC Residual Solvents (USP <467>)
Headspace Gas Chromatography with Flame Ionization Detection (HS-GC-FID) screening Class 1, 2, and 3 organic solvents strictly adhering to ICH Q3C guidelines.
- n-Hexane Limit ≤ 1 ppm
- Methanol / Ethyl Acetate Clear
- Thermal Stability Verified
ICP-MS Elemental Impurities (ICH Q3D)
Inductively Coupled Plasma Mass Spectrometry verifying trace heavy metals (Pb, Cd, Hg, As) and Class 1/2A catalytic metals to sub-parts-per-million (ppm) levels.
- Heavy Metals < 0.1 ppm
- Catalysts (Pd, Pt, Ni) Cleared
- USP <232> / <233> Compliant
Application & Formulation Engineering: Solving R&D Processing Bottlenecks
Bridging the gap between raw bioactive molecules and high-speed industrial manufacturing. We optimize physical particle morphology, dissolution kinetics, and bioburden controls tailored to your specific dosage delivery systems.
Oral Solid Dosage (Tablets & Hard Capsules)
Engineered for high-speed tableting (100,000+ tab/hr) and direct compression (DC Grade) lines, eliminating capping, sticking, and die-filling segregation.
Liquid, Sublingual & Parenteral Formulations
Optimized for rapid aqueous dissolution, sublingual transmucosal permeability, and ultra-low bioburden requirements in drops, syrups, and injectables.
Biotech & Life Science Cell Culture Grade
Research-grade raw materials for mammalian cell culture media, bioprocessing, mitochondrial research, and longevity therapeutic development.
Technical Knowledge Hub: Intercepting R&D Comparison & Regulatory Benchmarks
Empowering formulators, analytical scientists, and QA procurement heads with authoritative comparative technical guides, solvent clearance methodologies, and DMF/CEP qualification frameworks.
Natural Botanical Berberine HCl vs. Synthetic Analogs: Impurity Profile & Bioavailability Comparison
A comprehensive analytical comparison evaluating HPLC impurity peak patterns, residual solvent carryover, and trace genotoxic nitrosamine risk between plant-extracted Berberine (Phellodendron / Berberis) and chemical synthesis routes.
- HPLC-DAD & LC-MS/MS impurity fingerprinting
- Synthetic byproduct detection (azido/chloro derivatives)
- Bioequivalence & crystalline polymorph stability
USP <467> & ICH Q3C Residual Solvent Limits in High-Purity Active Ingredients
A practical compliance breakdown for pharmaceutical developers: How to set validated HS-GC testing protocols, establish Class 1/2 solvent clearance thresholds, and avoid batch rejections during FDA and EMA filings.
- Class 1, 2, and 3 organic volatile impurities (OVI)
- Headspace GC-FID method validation parameters
- Eliminating methanol, toluene & methylene chloride risk
How to Qualify Botanical API Suppliers for Global Regulatory Filings (US FDA DMF & EU CEP)
Step-by-step regulatory roadmap for qualifying raw material manufacturers: Navigating Active Substance Master Files (ASMF), Certificate of Suitability (CEP), supply chain traceability audits, and cGMP compliance dossiers.
- US FDA Type II DMF submission protocols
- EDQM CEP application & annual maintenance
- On-site vs. remote cGMP audit checklists
HPAI & API Technical Resource Center
Accelerate your R&D process with our validated technical dossiers and regulatory guides.
2026 Full API Catalog & DMF List
Access our complete technical database of 100+ high-purity molecules for global pharmaceutical sourcing.
🔒Secure Download: TDS/SDS/DMF SummariesSample Technical Dossier (Paracetamol)
Review our documentation depth, including HPLC-DAD impurity studies and detailed batch analysis reports.
View SampleICH Stability Study Methodology
Learn about our validated 24-month stability protocols conducted under global ICH Q1A guidelines.
Request Access
Solve Your Formulation Paradox Today
Struggling with ingredient fallout, oxidative instability, or regulatory roadblocks? Don’t let raw material variables stall your innovation. Connect directly with our Senior Engineering Team to discuss your specific purity and stability requirements.
Technical & Commercial Intelligence: API Sourcing FAQ
A: Yes. We understand that an API is only as good as its paperwork. For our flagship molecules like Paracetamol and Berberine HCl, we provide complete technical dossiers including DMF (Type II/IV), CEP/COS support, and manufacturing flowcharts. Our documentation is designed to pass the most stringent FDA and EFSA regulatory audits.
A: Absolutely. Formulation success depends on physical chemistry. Exbiol offers Advanced Particle Engineering, including Micronization (D90 < 10μm) via air-jet milling. We can customize Bulk and Tapped Density to ensure optimal flowability for high-speed tableting or uniform dispersion in liquid tinctures.
A: We support the entire product lifecycle. For R&D and pilot-scale validation, our MOQ starts at 1kg – 5kg. For mass commercial production, we typically supply in 25kg drums, with a manufacturing capacity exceeding 1,200 tons annually for core APIs to ensure supply chain security.
A: Stability is verified under ICH Q1A (R2) guidelines. To prevent degradation during sea or air freight, our APIs are vacuum-sealed in multi-layer OPA/ALU/PE moisture-barrier bags under a nitrogen blanket. Every shipment is accompanied by batch-specific stability statements and HPLC analysis.
A: Yes. Leveraging our 29 years of phytochemical expertise, we provide contract research and manufacturing (CRAMS) for specific isolates. If you require a high-purity marker not found in our standard catalog, our R&D team can develop a custom isolation protocol from pilot to multi-ton scale.
Technical Intelligence & Regulatory Support
Yes. Exbiol provides comprehensive Type II DMFs (US/EU) and CEP/COS documentation for our core APIs, including Paracetamol and Berberine HCl. Our regulatory team ensures that all dossiers strictly follow ICH M4 guidelines (CTD format), facilitating seamless submissions to the FDA, EMA, and other Tier-1 regulatory bodies.
Absolutely. We utilize advanced Jet Milling technology to provide particle size customization (Micronization). We can achieve D90 < 10μm or specific distributions tailored to enhance the bioavailability and dissolution rates of your final dosage forms (Tablets, Capsules, or Suspensions).
Every batch is validated via Waters™ HPLC-DAD and Agilent™ ICP-MS. We conduct rigorous Nitrosamine Risk Assessments and elemental impurity testing (ICH Q3D) to ensure that our botanical isolates reach 99.5%+ purity, with single impurities controlled well below the 0.10% threshold required by global pharmacopeias.
For commercial-scale supply, our standard lead time is 4-6 weeks from our GMP-certified facility. Our MOQ for standard APIs like Paracetamol is 1,200 Tons/Year capacity, while high-value intermediates start from 100kg, supported by full batch-to-batch consistency reports.